National Pharmacopoeia Commission revised the drug standard of Yaobitong capsule and Ginkgo biloba extract
-
Last Update: 2018-10-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In order to widely solicit opinions from all sectors of the society and enhance the attention, attention and participation of pharmaceutical manufacturers in the proposed revised content of the quality standard, the draft quality standard of Yaobitong capsule, which is to be revised in the 2015 edition of Chinese Pharmacopoeia, is hereby publicized for three months Please study and verify carefully In case of any objection, please send a letter in time with relevant instructions, experimental data and contact information If there is no opinion at the expiration of the publicity period, it shall be deemed that there is no objection to the content of the proposed revised draft Announcement on the proposed revision standard of Ginkgo biloba extract, Volume I, Chinese Pharmacopoeia, 2015 In order to widely solicit opinions from all sectors of the society and enhance the attention, attention and participation of pharmaceutical manufacturers in the proposed revision of the quality standard, the proposed revision draft of the quality standard of Ginkgo biloba extract, part I of Chinese Pharmacopoeia (2015 Edition) is hereby publicized for three months Please study and verify carefully In case of any objection, please send a letter in time with relevant instructions, experimental data and contact information If there is no opinion at the expiration of the publicity period, it shall be deemed that there is no objection to the content of the proposed revised draft Appendix: public draft of Ginkgo biloba extract
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
